Alert message
Alert message

Targeted Approaches to Treating B-cell Malignancies

Topics include: Treatment
Published on

Email this program

Get Link

Dr. Leo Gordon, from Northwestern Memorial Hospital, reviews the developing paradigm shift in the way that lymphomas are treated. He talks about the move from aggressive chemotherapy to more targeted treatments and explores how new categories of medicines, such as monoclonal antibodies and targeted small molecule inhibitors, or pills, may allow people to manage their disease as a chronic condition. Overall, Dr. Gordon is overwhelmingly positive about the future of treatment for lymphomas with novel therapies currently in clinical trials and those that are still in the early stages of development.

Stay Connected, Sign Up for Alerts!

Be the first to know about new programs and information with email alerts.

Patient Power values your trust and respects your privacy. We will only send you the email you have requested and we will never sell your information to anyone.

See a sample email
Read our full privacy policy
  • Chronic Lymphocytic Leukemia
  • Lymphoma

Related Programs


Page last updated on March 5, 2014